The current FTRE market cap is 2.59B. The company's latest EPS is USD -0.0380 and P/E is -760.53.
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 0 | 3.11B |
Operating Income | 0 | 63.3M |
Net Income | 0 | -3.4M |
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 4.29B | 4.36B |
Total Liabilities | 945.3M | 2.62B |
Total Equity | 3.34B | 1.74B |
Market Cap | 2.59B |
Price to Earnings Ratio | -760.53 |
Price to Sales Ratio | 0.83 |
Price to Cash Ratio | 23.79 |
Price to Book Ratio | 1.49 |
Dividend Yield | - |
Shares Outstanding | 89.4M |
Average Volume (1 week) | 3.1M |
Average Volume (1 Month) | 1.4M |
52 Week Change | -14.32% |
52 Week High | 41.02 |
52 Week Low | 24.925 |
Spread (Intraday) | 0.03 (0.1%) |
Company Name | Fortrea Holdings Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.fortrea.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.